179 related articles for article (PubMed ID: 22419864)
1. Fibrinogen, chronic obstructive pulmonary disease (COPD) and outcomes in two United States cohorts.
Valvi D; Mannino DM; Müllerova H; Tal-Singer R
Int J Chron Obstruct Pulmon Dis; 2012; 7():173-82. PubMed ID: 22419864
[TBL] [Abstract][Full Text] [Related]
2. Fibrinogen, COPD and mortality in a nationally representative U.S. cohort.
Mannino DM; Valvi D; Mullerova H; Tal-Singer R
COPD; 2012 Aug; 9(4):359-66. PubMed ID: 22489912
[TBL] [Abstract][Full Text] [Related]
3. Lung function decline and outcomes in an adult population.
Mannino DM; Reichert MM; Davis KJ
Am J Respir Crit Care Med; 2006 May; 173(9):985-90. PubMed ID: 16439715
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease.
Thomsen M; Ingebrigtsen TS; Marott JL; Dahl M; Lange P; Vestbo J; Nordestgaard BG
JAMA; 2013 Jun; 309(22):2353-61. PubMed ID: 23757083
[TBL] [Abstract][Full Text] [Related]
5. Elevated circulating PAI-1 levels are related to lung function decline, systemic inflammation, and small airway obstruction in chronic obstructive pulmonary disease.
Wang H; Yang T; Li D; Wu Y; Zhang X; Pang C; Zhang J; Ying B; Wang T; Wen F
Int J Chron Obstruct Pulmon Dis; 2016; 11():2369-2376. PubMed ID: 27713627
[TBL] [Abstract][Full Text] [Related]
6. Type IV collagen turnover is predictive of mortality in COPD: a comparison to fibrinogen in a prospective analysis of the ECLIPSE cohort.
Rønnow SR; Sand JMB; Langholm LL; Manon-Jensen T; Karsdal MA; Tal-Singer R; Miller BE; Vestbo J; Leeming DJ
Respir Res; 2019 Apr; 20(1):63. PubMed ID: 30935391
[TBL] [Abstract][Full Text] [Related]
7. Albuminuria, Lung Function Decline, and Risk of Incident Chronic Obstructive Pulmonary Disease. The NHLBI Pooled Cohorts Study.
Oelsner EC; Balte PP; Grams ME; Cassano PA; Jacobs DR; Barr RG; Burkart KM; Kalhan R; Kronmal R; Loehr LR; O'Connor GT; Schwartz JE; Shlipak M; Tracy RP; Tsai MY; White W; Yende S
Am J Respir Crit Care Med; 2019 Feb; 199(3):321-332. PubMed ID: 30261735
[TBL] [Abstract][Full Text] [Related]
8. Assisted ventilation in COPD - association between previous hospitalizations and mortality.
Toft-Petersen AP; Torp-Pedersen C; Weinreich UM; Rasmussen BS
Int J Chron Obstruct Pulmon Dis; 2016; 11():935-43. PubMed ID: 27217743
[TBL] [Abstract][Full Text] [Related]
9. Impact of lung function on exacerbations, health care utilization, and costs among patients with COPD.
Ke X; Marvel J; Yu TC; Wertz D; Geremakis C; Wang L; Stephenson JJ; Mannino DM
Int J Chron Obstruct Pulmon Dis; 2016; 11():1689-703. PubMed ID: 27555759
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of a model to predict the risk of exacerbations in chronic obstructive pulmonary disease.
Bertens LC; Reitsma JB; Moons KG; van Mourik Y; Lammers JW; Broekhuizen BD; Hoes AW; Rutten FH
Int J Chron Obstruct Pulmon Dis; 2013; 8():493-9. PubMed ID: 24143086
[TBL] [Abstract][Full Text] [Related]
11. Lack of association of ischemic heart disease with COPD when taking into account classical cardiovascular risk factors.
Izquierdo JL; Martínez A; Guzmán E; de Lucas P; Rodríguez JM
Int J Chron Obstruct Pulmon Dis; 2010 Nov; 5():387-94. PubMed ID: 21103405
[TBL] [Abstract][Full Text] [Related]
12. Female reproductive history in relation to chronic obstructive pulmonary disease and lung function in UK biobank: a prospective population-based cohort study.
Tang R; Fraser A; Magnus MC
BMJ Open; 2019 Oct; 9(10):e030318. PubMed ID: 31662371
[TBL] [Abstract][Full Text] [Related]
13. C-reactive protein levels in stable COPD patients: a case-control study.
Silva DR; Gazzana MB; Knorst MM
Int J Chron Obstruct Pulmon Dis; 2015; 10():1719-25. PubMed ID: 26357470
[TBL] [Abstract][Full Text] [Related]
14. Elevated plasma fibrinogen associated with reduced pulmonary function and increased risk of chronic obstructive pulmonary disease.
Dahl M; Tybjaerg-Hansen A; Vestbo J; Lange P; Nordestgaard BG
Am J Respir Crit Care Med; 2001 Sep; 164(6):1008-11. PubMed ID: 11587987
[TBL] [Abstract][Full Text] [Related]
15. Increased brachial intima-media thickness is associated with circulating levels of asymmetric dimethylarginine in patients with COPD.
Urban MH; Eickhoff P; Funk GC; Burghuber OC; Wolzt M; Valipour A
Int J Chron Obstruct Pulmon Dis; 2017; 12():169-176. PubMed ID: 28115840
[TBL] [Abstract][Full Text] [Related]
16. High levels of biomarkers of collagen remodeling are associated with increased mortality in COPD - results from the ECLIPSE study.
Sand JM; Leeming DJ; Byrjalsen I; Bihlet AR; Lange P; Tal-Singer R; Miller BE; Karsdal MA; Vestbo J
Respir Res; 2016 Oct; 17(1):125. PubMed ID: 27716343
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for FEV
Chen S; Wang C; Li B; Shi G; Li H; Zhang J; Gu Y; Zhou J; Song Y; Bai C
Int J Chron Obstruct Pulmon Dis; 2017; 12():435-442. PubMed ID: 28184155
[TBL] [Abstract][Full Text] [Related]
18. Long-term survival in patients hospitalized for chronic obstructive pulmonary disease: a prospective observational study in the Nordic countries.
Gudmundsson G; Ulrik CS; Gislason T; Lindberg E; Brøndum E; Bakke P; Janson C
Int J Chron Obstruct Pulmon Dis; 2012; 7():571-6. PubMed ID: 23055707
[TBL] [Abstract][Full Text] [Related]
19. The utility of inflammatory markers to predict readmissions and mortality in COPD cases with or without eosinophilia.
Duman D; Aksoy E; Agca MC; Kocak ND; Ozmen I; Akturk UA; Gungor S; Tepetam FM; Eroglu SA; Oztas S; Karakurt Z
Int J Chron Obstruct Pulmon Dis; 2015; 10():2469-78. PubMed ID: 26648709
[TBL] [Abstract][Full Text] [Related]
20. Fibrinogen is a promising biomarker for chronic obstructive pulmonary disease: evidence from a meta-analysis.
Zhou B; Liu S; He D; Wang K; Wang Y; Yang T; Zhang Q; Zhang Z; Niu W
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32677669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
